Tracon Pharmaceuticals, Inc. has received a Notice of Effectiveness from the United States Securities and Exchange Commission (SEC) on November 1, 2024. The notice, identified by Accession Number 0000950170-24-119579, pertains to the submission type POS AM. The company, with CIK number 0001394319, has its filing listed under the File Number 333-270589. This SEC filing indicates that Tracon Pharmaceuticals' registration statement or post-effective amendment has been declared effective, allowing the company to proceed with the securities offering detailed in the filing.

Tracon Pharmaceuticals, Inc. has received a Notice of Effectiveness from the United States Securities and Exchange Commission (SEC) on November 1, 2024. The notice, identified by Accession Number 0000950170-24-119579, pertains to the submission type POS AM. The company, with CIK number 0001394319, has its filing listed under the File Number 333-270589. This SEC filing indicates that Tracon Pharmaceuticals' registration statement or post-effective amendment has been declared effective, allowing the company to proceed with the securities offering detailed in the filing.